ProductsBack/KIF4A antibody [N1N2], N-term

KIF4A antibody [N1N2], N-term

Name: KIF4A antibody [N1N2], N-term
SKU: GTX115759_G10
Availability: BackOrder

GTX115759

ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Product group Antibodies

TargetKIF4A

Overview

Supplier
GeneTex
Product Name
KIF4A antibody [N1N2], N-term
Delivery Days Customer
9
Application Supplier Note
WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Applications
ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Certification
Research Use Only
Clonality
Polyclonal
Concentration
1 mg/ml
Conjugate
Unconjugated
Gene ID24137
Target name
KIF4A
Target description
kinesin family member 4A
Target synonyms
KIF4, KIF4G1, MRX100, TMDI, XLID100, chromosome-associated kinesin KIF4A, chromokinesin KIF4A, chromokinesin-A
Host
Rabbit
Isotype
IgG
Protein IDO95239
Protein Name
Chromosome-associated kinesin KIF4A
Scientific Description
Kinesins, such as KIF4A, are microtubule-based motor proteins that generate directional movement along microtubules. They are involved in many crucial cellular processes, including cell division (Zhu and Jiang, 2005 [PubMed 15625105]).[supplied by OMIM]
Storage Instruction
-20°C or -80°C,2°C to 8°C
UNSPSC
12352203

Lin N, Chen L, Zhang Y, et al. KIF4A promotes tumor progression of bladder cancer via CXCL5 dependent myeloid-derived suppressor cells recruitment. Sci Rep. 2022,12(1):6015. doi: 10.1038/s41598-022-10029-x
Read this paper
Chase A, Pellagatti A, Singh S, et al. PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia. Leukemia. 2019,33(5):1184-1194. doi: 10.1038/s41375-018-0340-5
Read this paper
Zhang Y, Liu S, Qu D, et al. Kif4A mediate the accumulation and reeducation of THP-1 derived macrophages via regulation of CCL2-CCR2 expression in crosstalking with OSCC. Sci Rep. 2017,7(1):2226. doi: 10.1038/s41598-017-02261-7
Read this paper
Lin J, Wang K, Wang H, et al. Fucoidan reduced the invasion of oral squamous cell carcinoma cells and modified their effects to macrophages. Med Oncol. 2017,34(1):9. doi: 10.1007/s12032-016-0858-1
Read this paper